(Q40592915)

English

Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance

scientific article published on October 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Oral ciprofloxacin plus colistin: prophylaxis against bacterial infection in neutropenic patients. A strategy for the prevention of emergence of antimicrobial resistance (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

author name string

Prentice HG

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Hann IM

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Nazareth B

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Paterson P

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Bhamra A

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Kibbler CC

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 October 2001

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

115

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

46-52

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Pharmacokinetics of ciprofloxacin

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Escherichia coli resistant to fluoroquinolones in patients with cancer and neutropenia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Effectiveness of antibiotic prophylaxis in critically ill adult patients: systematic review of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Efficacy of quinolone prophylaxis in neutropenic cancer patients: a meta-analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

In vitro activity of ciprofloxacin (Bay o 9867)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Cytokine dysregulation as a mechanism of graft versus host disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Influence of protective isolation on outcome of allogeneic bone marrow transplantation for leukemia.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Infections in acute leukemia: an analysis of 240 febrile episodes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Oral norfloxacin for prevention of gram-negative bacterial infections in patients with acute leukemia and granulocytopenia. A randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Emergence of fluoroquinolone-resistant Escherichia coli at a cancer center

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Activity of ciprofloxacin and colistin against Pseudomonas aeruginosa isolates from neutropenic patients: a possible approach to prophylaxis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Prediction of systemic fungal infection in allogeneic marrow recipients: impact of amphotericin prophylaxis in high-risk patients

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). The MCR Childhood Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Initial empirical antibiotic therapy for neutropenic fever: analysis of the causes of death

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Origin of infection in acute nonlymphocytic leukemia. Significance of hospital acquisition of potential pathogens.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Oral non-absorbed antibiotics prevent infection in acute non-lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Determination of the colonization resistance of the digestive tract of individual mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Prevention of infection by ciprofloxacin in neutropenia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Oral ciprofloxacin as antibacterial prophylaxis after allogeneic bone marrow transplantation: a reappraisal

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI)

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03034.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2001.03034.X

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40592915&oldid=1903480627"